Skip to main content
. 2018 Nov 19;30(1):79–92. doi: 10.1007/s00198-018-4732-1

Table 2.

Cumulative incidence of a subsequent incident fracture 1, 2, and 5 years after initial fracture, overall, and by skeletal location of initial fracture

1 yeara 2 yearsb 5 yearsc
Initial fracture site Number of patients % with subsequent fracture (95% CI) Number of patients % with subsequent fracture (95% CI) Number of patients % with subsequent fracture (95% CI)
Outcome: any fracture
 Any site 377,561 9.8 (9.7–9.9) 210,621 17.9 (17.7–18.1) 10,969 30.9 (30.0–31.7)
 Spine 111,382 14.1 (13.9–14.3) 62,906 25.5 (25.2–25.9) 3349 40.1 (38.4–41.8)
 Pelvis 23,113 11.8 (11.3–12.2) 13,004 20.2 (19.5–20.9) 673 30.5 (27.0–33.9)
 Clavicle 4661 10.6 (9.7–11.5) 2509 18.3 (16.8–19.8) 131 33.6 (25.5–41.7)
 Humerus 35,541 8.3 (8.0–8.6) 19,546 15.7 (15.2–16.2) 928 31.8 (28.8–34.8)
 Radius/ulna 56,265 7.2 (7.0–7.5) 30,990 13.9 (13.5–14.3) 1492 29.4 (27.1–31.7)
 Hip 96,090 8.3 (8.1–8.5) 53,987 15.0 (14.7–15.3) 3010 25.3 (23.8–26.9)
 Femur 12,615 7.3 (6.9–7.8) 7026 13.9 (13.1–14.7) 365 24.9 (20.5–29.4)
 Tibia/fibula 12,212 6.9 (6.5–7.4) 6761 12.1 (11.4–12.9) 363 18.7 (14.7–22.7)
 Ankle 25,682 4.6 (4.4–4.9) 13,892 9.5 (9.0–10.0) 658 21.0 (17.9–24.1)
Outcome: hip fracture
 Any site 377,561 2.4 (2.4–2.5) 210,621 4.8 (4.7–4.9) 10,969 10.2 (9.6–10.7)
 Spine 111,382 3.3 (3.2–3.4) 62,906 6.2 (6.0–6.4) 3349 12.1 (11.0–13.2)
 Pelvis 23,113 3.8 (3.5–4.0) 13,004 6.4 (6.0–6.9) 673 9.7 (7.4–11.9)
 Clavicle 4661 3.5 (3.0–4.0) 2509 6.3 (5.4–7.3) 131 12.2 (6.6–17.8)
 Humerus 35,541 2.8 (2.6–2.9) 19,546 5.2 (4.9–5.5) 928 12.9 (10.8–15.1)
 Radius/ulna 56,265 2.0 (1.9–2.2) 30,990 4.2 (4.0–4.5) 1492 10.6 (9.0–12.2)
 Hip 96,090 1.7 (1.6–1.8) 53,987 4.0 (3.8–4.1) 3010 9.0 (7.9–10.0)
 Femur 12,615 1.6 (1.4–1.9) 7026 3.5 (3.1–3.9) 365 6.3 (3.8–8.8)
 Tibia/fibula 12,212 1.7 (1.4–1.9) 6761 2.9 (2.5–3.3) 363 5.2 (2.9–7.5)
 Ankle 25,682 1.1 (1.0–1.3) 13,892 2.2 (2.0–2.4) 658 6.1 (4.3–7.9)

CI confidence interval

aAmong all women with at least 12 months of Medicare coverage parts A + B + D follow-up, or who died within the first 12 months

bAmong all women with at least 24 months of Medicare coverage parts A + B + D follow-up, or who died within the first 24 months

cAmong all women with at least 60 months of Medicare coverage parts A + B + D follow-up, or who died within the first 60 months